Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-22-018108
Filing Date
2022-06-29
Accepted
2022-06-29 16:21:16
Documents
105
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1917555
2 ex10-55.htm EX-10.55 13561
3 ex10-56.htm EX-10.56 15236
4 ex10-57.htm EX-10.57 783212
5 ex10-58.htm EX-10.58 15148
6 ex10-59.htm EX-10.59 408110
7 ex23-1.htm EX-23.1 4459
8 ex31-1.htm EX-31.1 19345
9 ex31-2.htm EX-31.2 19323
10 ex32-1.htm EX-32.1 6554
11 ex32-2.htm EX-32.2 6417
12 ex10-55_001.jpg GRAPHIC 13314
13 ex10-56_001.jpg GRAPHIC 2841
14 ex10-58_001.jpg GRAPHIC 3752
15 ex10-59_001.jpg GRAPHIC 271603
16 ex10-59_002.jpg GRAPHIC 168730
  Complete submission text file 0001493152-22-018108.txt   9586114

Data Files

Seq Description Document Type Size
17 XBRL SCHEMA FILE eltp-20220331.xsd EX-101.SCH 62502
18 XBRL CALCULATION FILE eltp-20220331_cal.xml EX-101.CAL 76540
19 XBRL DEFINITION FILE eltp-20220331_def.xml EX-101.DEF 207860
20 XBRL LABEL FILE eltp-20220331_lab.xml EX-101.LAB 474472
21 XBRL PRESENTATION FILE eltp-20220331_pre.xml EX-101.PRE 361998
99 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 994795
Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647
Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646
ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)

EIN.: 223542636 | State of Incorp.: NJ | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 001-15697 | Film No.: 221054902
SIC: 2834 Pharmaceutical Preparations